MedTrace Logo

Efficacy and Tolerance of Therapeutic Apheresis in Paediatric Neurology: a French Multicenter Study

NCT04845516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-04-12

No results posted yet for this study

Summary

After developing in pediatric hematology and nephrology, therapeutic apheresis is increasingly used in pediatric neurology despite a sparse level of evidence.

There are a few retrospective series with a small number of patients, concerning mainly autoimmune diseases (encephalitis, myasthenia gravis, polyradiculoneuritis).

The objective of this work is to study therapeutic apheresis (including plasma exchange and immunoadsorption) among french neuropediatric tertiary centers and to prove that this treatment modality is effective and well tolerated in pediatric neurology diseases.

Conditions

  • Apheresis Related Complication

Interventions

OTHER

Efficacy of apheresis

Efficacy of apheresis

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Maxime colmard, résident · University Hospitals of Montpellier

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-12-01
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845516 on ClinicalTrials.gov